Integrative Molecular Characterization of Breast Cancer
Demographics (1)
- SEX - Self-reported sex (phv00491470.v2.p1)
Disease Events (8)
- AFFECTION_STATUS - Case control status of the subject for breast cancer (phv00491476.v2.p1)
- AGE_ONSET - Disease onset age (phv00491474.v2.p1)
- IS_TUMOR - Tumor status (phv00491479.v2.p1)
- MOLECULAR_TYPE - Molecular type of Breast Cancer (phv00542910.v1.p1)
- PRIMARY_TUMOR_LOCATION - Primary tumor location (phv00491482.v2.p1)
- STAGE - Cancer stage (phv00542909.v1.p1)
- TUMOR_GRADE - Tumor grade of sample (phv00542911.v1.p1)
- TUMOR_STAGE - Tumor stage of sample (phv00542912.v1.p1)
Race and Ethnicity (2)
- ETHNICITY - Self-reported ethnicity (phv00542908.v1.p1)
- RACE - Self-reported race (phv00491475.v2.p1)
Other (12)
- ANALYTE_TYPE - Analyte Type (phv00491478.v2.p1)
- BODY_SITE - Body site where sample was collected (phv00542915.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00491469.v2.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00491480.v2.p1)
- PRIMARY_METASTATIC_TUMOR - Primary tumor, metastasis, or transformed cell line (phv00491481.v2.p1)
- SAMPLE_ID - Sample ID (phv00491477.v2.p1)
- SAMPLE_ID - Sample ID (phv00491472.v2.p1)
- SUBJECT_ID - Subject ID (phv00491473.v2.p1)
- SUBJECT_ID - Subject ID (phv00491468.v2.p1)
- SUBJECT_ID - Subject ID (phv00491471.v2.p1)
- TREATMENT_ARM - Treatment regimen undergone (phv00542914.v1.p1)
- TREATMENT_TIMEPOINT - Timepoint of treatment (phv00542913.v1.p1)